Vertex Pharmaceuticals got a healthy boost on Tuesday, with shares climbing nearly 3% thanks to a double dose of analyst ...

FILE - Boston City Councilor Tania Fernandes Anderson addresses Boston City Council members during a meeting at City Hall in Boston, Wednesday, Oct. 25, 2023. (AP Photo/Steven Senne, File ...

In this article, we are going to take a look at where Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) stands against other best long term growth stocks to buy according to billionaires.

Investors seeking relief from the stock market turbulence at the start of 2025 should take a close look at Vertex Pharmaceuticals (NASDAQ: VRTX). Compared to the S&P 500 index, which is down about ...

Will these developments be enough to sustain the rally? Let's discuss whether Vertex Pharmaceuticals stock is a buy now. The past year has been transformative for Vertex, marked by the launch of ...

Hemas Pharmaceuticals and Hemas Surgicals & Diagnostics has appointed Dr. Mahesha Ranasoma as its Managing Director, effective April 2, 2025. For over six decades, Hemas Pharmaceuticals has played ...

BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (VRTX) (Nasdaq: VRTX) will report its first quarter 2025 financial results on Monday, May 5, 2025 after the financial markets close.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vertex Pharmaceuticals (VRTX – Research Report) and Apellis Pharmaceuticals (APLS – Research Report).